Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Mallinckrodt
Baxter
Johnson and Johnson
AstraZeneca

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Xenon xe-133 - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for xenon xe-133 and what is the scope of freedom to operate?

Xenon xe-133 is the generic ingredient in three branded drugs marketed by Curium, Ge Healthcare, Gen Electric, Lantheus Medcl, and Mallinckrodt, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for xenon xe-133. Two suppliers are listed for this compound.

Summary for xenon xe-133
US Patents:0
Tradenames:3
Applicants:5
NDAs:7
Drug Master File Entries: 12
Suppliers / Packagers: 2
DailyMed Link:xenon xe-133 at DailyMed
Pharmacology for xenon xe-133

US Patents and Regulatory Information for xenon xe-133

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare XENON XE 133-V.S.S. xenon xe-133 GAS;INHALATION 017687-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ge Healthcare XENON XE 133 xenon xe-133 INJECTABLE;INJECTION 017256-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Gen Electric XENON XE 133 xenon xe-133 GAS;INHALATION 017550-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ge Healthcare XENON XE 133 xenon xe-133 GAS;INHALATION 017687-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Curium XENON XE 133 xenon xe-133 GAS;INHALATION 018327-002 Mar 9, 1982 RX No No   Start Trial   Start Trial   Start Trial
Lantheus Medcl XENON XE 133 xenon xe-133 INJECTABLE;INJECTION 017283-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Gen Electric XENON XE 133 xenon xe-133 GAS;INHALATION 017550-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKinsey
Colorcon
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.